RIXATHON

Concentrate for solution for infusion, 500mg/50ml
RxActive license

Active substance (INN)

rituximab

Pharmaceutical form

Pharmaceutical formConcentrate for solution for infusion
Strength500mg/50ml
PackagingUkupno 1 bočica staklena sa 50ml koncentrata za rastvor za infuziju u kartonskoj kutiji
ManufacturerSandoz GmbH Schaftenau, Austria
Therapeutic groupAntineoplastic and immunomodulating agents (L01FA01)
Marketing authorization holderDRUŠTVO ZA TRGOVINU NA VELIKO FARMACEUTSKIM PROIZVODIMA "GLOSARIJ" D.O.O.-PODGORICA
Authorization dateDecember 29, 2025

Analogs in Montenegro

7

Other medicines with the same active substance

MABTHERARx
Solution for injection, 1400mg/11.7mlF. Hoffmann-La Roche AG
MABTHERARx
Solution for injection, 1600mg/13.4mlF. Hoffmann-La Roche AG
MABTHERARx
Concentrate for solution for infusion, 500mg/50mlF.Hoffmann-La Roche Ltd.
MABTHERARx
Concentrate for solution for infusion, 100mg/10mlF.Hoffmann-La Roche Ltd.
RIXATHONRx
Concentrate for solution for infusion, 100mg/10mlSandoz GmbH Schaftenau
RUXIENCERx
Concentrate for solution for infusion, 100mgPfizer Manufacturing Belgium NV
RUXIENCERx
Concentrate for solution for infusion, 500mgPfizer Manufacturing Belgium NV
Source: CInMED register